BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Naqvi SAR, Rasheed R, Ahmed MT, Zahoor AF, Khalid M, Mahmood S. Radiosynthesis and preclinical studies of 177Lu-labeled sulfadiazine: a possible theranostic agent for deep-seated bacterial infection. J Radioanal Nucl Chem 2017;314:1023-9. [DOI: 10.1007/s10967-017-5477-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
Number Citing Articles
1 Karpuz M, Özgenç E, Gündoğdu E, Burak Z. Enfeksiyon Görüntüleme ve Tedavisi için 177Lutesyum-Tedizolid. Fabad J Pharm Sci 2022. [DOI: 10.55262/fabadeczacilik.1099287] [Reference Citation Analysis]
2 Shetty Y, Prabhu P, Prabhakar B. Emerging vistas in theranostic medicine. Int J Pharm 2019;558:29-42. [PMID: 30599229 DOI: 10.1016/j.ijpharm.2018.12.068] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
3 Khan NUH, Naqvi SAR, Roohi S, Sherazi TA, Khan ZA, Zahoor AF. Technetium-99m radiolabeling and biological study of epirubicin for in vivo imaging of multi-drug-resistant Staphylococcus aureus infections via single photon emission computed tomography. Chem Biol Drug Des 2019;93:154-62. [PMID: 30216686 DOI: 10.1111/cbdd.13393] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
4 Kumar C, Sharma R, Vats K, Mallia MB, Das T, Sarma HD, Dash A. Comparison of the efficacy of 177Lu-EDTMP, 177Lu-DOTMP and 188Re-HEDP towards bone osteosarcoma: an in vitro study. J Radioanal Nucl Chem 2019;319:51-9. [DOI: 10.1007/s10967-018-6283-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]